Patients with advanced lung cancer who received immunochemotherapy before 15:00 (3 p.m.) had a more delayed disease ...

For patients with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer, the addition of palbociclib to maintenance anti-HER2 and endocrine ...

Akeega, an oral dual mechanism therapy pairing niraparib with abiraterone, has won a positive committee opinion in Europe for ...

A curious phenomenon seen by oncologists, that morning patients do better than those receiving afternoon infusions, gains ...

Johns Hopkins University cancer researcher Mikala Egeblad has received the 2025 Ernst W. Bertner Memorial Award in ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...

A bacterium best known for causing gum disease may also influence how breast cancer begins and spreads. A team at the Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy r ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer ...

One of the most important developments in breast cancer, especially for people with hormone receptor-positive (HR+) advanced ...

Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible ...

PrECOG, LLC, today announced the publication of final results from the pivotal phase 3 PATINA study in the New England ...